MedCap AB (publ)
MCAP
Rank in Stocks
#9448
MedCap AB (publ) operates as a private equity firm, employing a diverse array... MedCap AB (publ) operates as a private equity firm, employing a diverse array of investment strategies including secondary direct deals, later-stage funding, industry consolidation, growth capital provision, engagement with middle-market and mature businesses, turnarounds, and outright buyouts. The company primarily directs its capital towards businesses within the healthcare sector, focusing on medical equipment and services, biotechnology, life sciences, and pharmaceuticals. It actively seeks unlisted, small to mid-sized companies located predominantly across Northern Europe. Equity investments typically fall within the SEK 25 million to SEK 150 million range (approximately $2.75 million to $16.51 million). Target companies generally exhibit an enterprise value and annual sales revenue between SEK 50 million and SEK 200 million ($5.90 million to $23.06 million), alongside an EBITDA of SEK 1 million to SEK 50 million ($0.11 million to $5.50 million). MedCap aims to acquire ownership stakes of 20% to 50% in its portfolio entities, financing these through its own capital, loans, and direct balance sheet investments. Established in 2001, the firm maintains its headquarters in Stockholm, Sweden.
Share Price
$56.57
Last synced: 2026-11-09
Market Cap
$847.23M
Change (1 day)
-0.25%
Change (1 year)
-2.18%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade MedCap AB (publ) (MCAP)
Category
Healthcare
EPS for MedCap AB (publ) (MCAP)
EPS as of September 2026 TTM: $1.85
According to MedCap AB (publ)'s latest financial reports, its current EPS (TTM) is $1.85. At the end of 2025 the company had an EPS of $1.59, an increase over its 2024 EPS of $1.27.
EPS history for MedCap AB (publ) from 2008 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $1.85 | 16.04% |
| 2025 | $1.59 | 25.34% |
| 2024 | $1.27 | 10.04% |
| 2023 | $1.15 | 51.39% |
| 2022 | $0.76 | 5.71% |
| 2021 | $0.72 | 40.40% |
| 2020 | $0.51 | 20.05% |
| 2019 | $0.43 | 8,448.00% |
| 2018 | $0.01 | -79.59% |
| 2017 | $0.02 | -86.87% |
| 2016 | $0.19 | 160.25% |
| 2015 | $0.07 | -75.45% |
| 2014 | $0.29 | 35.99% |
| 2013 | $0.21 | 60.78% |
| 2012 | $0.13 | -32.97% |
| 2011 | $0.20 | 188.42% |
| 2010 | $0.07 | 2,129.03% |
| 2009 | 0.00 | -102.78% |
| 2008 | $-0.11 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $44.57 | 2,315.72% |
US
|
|
| $4.53 | 145.53% |
US
|
|
| $7.07 | 283.42% |
SE
|
|
| $3.36 | 82.11% |
US
|
|
| $0.35 | -81.03% |
US
|
Questions about MedCap AB (publ)'s earnings per share (EPS)
What is MedCap AB (publ)'s earnings per share (EPS)?
MedCap AB (publ)'s earnings per share (EPS) over the last twelve months is $1.85, as of Sep 2026.
What was MedCap AB (publ)'s earnings per share (EPS) in 2025?
In 2025, MedCap AB (publ)'s earnings per share (EPS) was $1.59, 25.20% more than in 2024 ($1.27).
How has MedCap AB (publ)'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, MedCap AB (publ)'s earnings per share (EPS) went from $0.51 to $1.59, an average growth of 25.54% a year.
How does MedCap AB (publ)'s earnings per share (EPS) compare with similar companies?
MedCap AB (publ)'s earnings per share (EPS) ($1.85) is higher than that of 1 of the 5 similar companies listed above. The highest among them is BlackRock, Inc., with $44.57.